Granules India Limited has informed the Exchange regarding a press release dated February 24, 2021, titled "Granules India Limited announces approval of Acetaminophen, Aspirin and Caffeine Tablets (OTC), generic equivalent of Excedrin Migraine Tablets of GlaxoSmithKline Consumer Healthcare".